PDG109 REPLACING BRANDED ANTINEOPLASTIC DRUGS WITH GENERICS OR BIOSIMILARS: FORCAST OF BUDGET SAVINGS FOR THE PERSPECTIVE PERIOD

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1122
https://www.valueinhealthjournal.com/article/S1098-3015(19)33500-4/fulltext
Title : PDG109 REPLACING BRANDED ANTINEOPLASTIC DRUGS WITH GENERICS OR BIOSIMILARS: FORCAST OF BUDGET SAVINGS FOR THE PERSPECTIVE PERIOD
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33500-4&doi=10.1016/j.jval.2019.09.1122
First page :
Section Title :
Open access? : No
Section Order : 10982
Categories :
Tags :
Regions :
ViH Article Tags :